Glenmede Trust’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.32M Sell
7,345
-235
-3% -$40.1K 0.01% 659
2025
Q4
$1.07M Buy
+7,580
New +$860K 0.01% 714
2025
Q1
$202K Sell
2,801
-2,360
-46% -$192K ﹤0.01% 1208
2024
Q4
$444K Buy
5,161
+1,790
+53% +$178K ﹤0.01% 978
2024
Q3
$319K Buy
3,371
+1,252
+59% +$111K ﹤0.01% 1075
2024
Q2
$202K Sell
2,119
-1,736
-45% -$206K ﹤0.01% 1194
2024
Q1
$508K Buy
+3,855
New +$475K ﹤0.01% 922
2023
Q3
Sell
-1,558
Closed -$344K 1258
2023
Q2
$344K Hold
1,558
﹤0.01% 944
2023
Q1
$344K Buy
1,558
+81
+5% +$20K ﹤0.01% 949
2022
Q4
$320K Buy
1,477
+289
+24% +$77K ﹤0.01% 970
2022
Q3
$314K Buy
+1,188
New +$302K ﹤0.01% 936
2020
Q4
Sell
-76
Closed -$6K 1225
2020
Q3
$6K Buy
76
+36
+90% +$3.19K ﹤0.01% 2026
2020
Q2
$3K Sell
40
-251
-86% -$17.1K ﹤0.01% 2160
2020
Q1
$21K Hold
291
﹤0.01% 2067
2019
Q4
$21K Sell
291
-11,801
-98% -$788K ﹤0.01% 2067
2019
Q3
$839 Buy
12,092
+11,809
+4,173% +$804K ﹤0.01% 769
2019
Q2
$19 Sell
283
-7,052
-96% -$521K ﹤0.01% 2072
2019
Q1
$601 Buy
7,335
+19
+0.3% +$1.55K ﹤0.01% 845
2018
Q4
$563 Buy
7,316
+2
+0% +$189 ﹤0.01% 837
2018
Q3
$729K Hold
7,314
﹤0.01% 817
2018
Q2
$690K Buy
7,314
+7,049
+2,660% +$677K ﹤0.01% 776
2018
Q1
$33K Hold
265
﹤0.01% 1779
2017
Q4
$33K Buy
265
+36
+16% +$4.88K ﹤0.01% 1779
2017
Q3
$31K Sell
229
-669
-74% -$79.5K ﹤0.01% 1821
2017
Q2
$94K Hold
898
﹤0.01% 1401
2017
Q1
$94K Sell
898
-913
-50% -$88.8K ﹤0.01% 1401
2016
Q4
$155K Sell
1,811
-235
-11% -$19.9K ﹤0.01% 1276
2016
Q3
$174K Buy
2,046
+94
+5% +$7.74K ﹤0.01% 1235
2016
Q2
$154K Sell
1,952
-20,133
-91% -$1.48M ﹤0.01% 1252
2016
Q1
$1.41M Sell
22,085
-270
-1% -$14.8K 0.01% 677
2015
Q4
$1.25M Buy
22,355
+20,677
+1,232% +$1.06M 0.01% 712
2015
Q3
$73K Sell
1,678
-7,098
-81% -$346K ﹤0.01% 1464
2015
Q2
$484K Sell
8,776
-19,563
-69% -$1.17M ﹤0.01% 956
2015
Q1
$1.5M Sell
28,339
-331,192
-92% -$18.1M 0.01% 665
2014
Q4
$21.6M Buy
359,531
+134,391
+60% +$7.92M 0.17% 180
2014
Q3
$13.3M Buy
225,140
+199,455
+777% +$13M 0.12% 260
2014
Q2
$1.84M Buy
25,685
+13,253
+107% +$909K 0.02% 563
2014
Q1
$825K Buy
12,432
+1,463
+13% +$94.7K 0.01% 748
2013
Q4
$694K Sell
10,969
-2,002
-15% -$133K 0.01% 769
2013
Q3
$815K Sell
12,971
-149
-1% -$9.39K 0.01% 705
2013
Q2
$816K Buy
+13,120
New +$824K 0.01% 666

Other funds holding ALB

Glenmede Trust's ALB Position: Q1 2026 in Review

Glenmede Trust reduced its Albemarle (ALB) stake by 3.1% in Q1 2026, selling an estimated $40.1K and leaving 7,345 shares worth $1.32M. The position accounts for 0.01% of the portfolio, ranked #659.

Glenmede Trust first reported a position in ALB in Q2 2013 and has held it in 41 quarters since. The position peaked at $21.6M in Q4 2014. 982 funds tracked by Wall St. Rank hold ALB as of Q1 2026.

  • Glenmede Trust held 7,345 shares of Albemarle worth $1.32M as of Q1 2026.
  • Glenmede Trust sold 235 Albemarle shares in Q1 2026, an estimated $40.1K.
  • Albemarle made up 0.01% of Glenmede Trust's portfolio in Q1 2026, its #659 holding.
  • Glenmede Trust first reported a position in Albemarle in Q2 2013 and has held it in 41 quarters since.
  • Glenmede Trust's Albemarle position peaked at $21.6M in Q4 2014.
  • 982 funds tracked by Wall St. Rank held Albemarle as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.